I haven't seen anything to suggest that this is definitely off track. The peer review phase may take about 3 months*, which means that the results can be verified and peer-reviewed by March (which is still Q1 2018). The timeline only says that these results are likely to be published in the Q2 edition of a medical journal.
With the peer-reviewed clinicial trial data, the FDA shouldn't take more than 3 weeks* to process and hopefully approve a submission.
* I got these estimates from asking a friend who is doing his Masters after graduating in Medical Science. So I'm not claiming to know these timeframes for sure, but he probably knows a thing or two about the scientific process in medical research
- Forums
- ASX - By Stock
- anticipated results
I haven't seen anything to suggest that this is definitely off...
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.8¢ |
Change
0.001(1.75%) |
Mkt cap ! $60.00M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.8¢ | $61.32K | 1.042M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 188378 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 490015 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 88378 | 0.058 |
1 | 100000 | 0.057 |
4 | 267571 | 0.056 |
3 | 1382636 | 0.055 |
2 | 571649 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 490015 | 8 |
0.061 | 471997 | 2 |
0.064 | 200000 | 1 |
0.065 | 56436 | 2 |
0.066 | 166666 | 1 |
Last trade - 15.52pm 15/11/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online